{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:33:09Z","timestamp":1772155989421,"version":"3.50.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/hjh.0b013e3282a9be30","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T18:02:14Z","timestamp":1236189734000},"page":"2131-2137","source":"Crossref","is-referenced-by-count":30,"title":["Aldosterone excess and resistance to 24-h blood pressure control"],"prefix":"10.1097","volume":"25","author":[{"given":"Eduardo","family":"Pimenta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna K","family":"Gaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique N","family":"Pratt-Ubunama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari K","family":"Nishizaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey S","family":"Cofield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Oparil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Calhoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-25-20210208","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"R2-25-20210208","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio","volume":"37","author":"Gallay","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R3-25-20210208","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","article-title":"Low-renin status in therapy-resistant hypertension: a clue to efficient treatment","volume":"22","author":"Eide","year":"2004","journal-title":"J Hypertens"},{"key":"R4-25-20210208","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region","volume":"17","author":"Strauch","year":"2003","journal-title":"J Hum Hypertens"},{"key":"R5-25-20210208","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa022273","article-title":"Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension","volume":"348","author":"Clement","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-25-20210208","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.HYP.0000170138.56903.7a","article-title":"Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study","volume":"46","author":"Dolan","year":"2005","journal-title":"Hypertension"},{"key":"R7-25-20210208","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.amjhyper.2005.09.018","article-title":"Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study","volume":"19","author":"Hansen","year":"2006","journal-title":"Am J Hypertens"},{"key":"R8-25-20210208","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/01.CIR.88.3.986","article-title":"Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events","volume":"88","author":"Verdecchia","year":"1993","journal-title":"Circulation"},{"key":"R9-25-20210208","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/jama.1989.03420060089038","article-title":"Average daily blood pressure, not office pressure, determines cardiac function in patients with hypertension","volume":"261","author":"White","year":"1989","journal-title":"JAMA"},{"key":"R10-25-20210208","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1161\/01.CIR.0000056521.67546.AA","article-title":"Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study","volume":"107","author":"Kario","year":"2003","journal-title":"Circulation"},{"key":"R11-25-20210208","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.HYP.0000198541.12640.0f","article-title":"Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study","volume":"47","author":"Metoki","year":"2006","journal-title":"Hypertension"},{"key":"R12-25-20210208","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.HYP.31.2.712","article-title":"Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study","volume":"31","author":"Redon","year":"1998","journal-title":"Hypertension"},{"key":"R13-25-20210208","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"R14-25-20210208","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R15-25-20210208","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ajh\/6.1.8","article-title":"Prevalence of extracranial carotid artery lesions at duplex in primary aldosteronism","volume":"6","author":"Rossi","year":"1993","journal-title":"Am J Hypertens"},{"key":"R16-25-20210208","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347840","article-title":"Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension","volume":"18","author":"Takeda","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"R17-25-20210208","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(99)70298-2","article-title":"Cardiovascular complications in patients with primary aldosteronism","volume":"33","author":"Nishimura","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R18-25-20210208","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in left ventricular anatomy and function in hypertension and primary aldosteronism","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"key":"R19-25-20210208","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"R20-25-20210208","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.HYP.0000154364.00763.d5","article-title":"Hyperaldosteronism and hypertension: ethnic differences","volume":"45","author":"Grim","year":"2005","journal-title":"Hypertension"},{"key":"R21-25-20210208","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ncpneph0151","article-title":"Primary aldosteronism: diagnostic and treatment strategies","volume":"2","author":"Mattsson","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"R22-25-20210208","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00126097-200310000-00001","article-title":"Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension","volume":"8","author":"Muxfeldt","year":"2003","journal-title":"Blood Press Monit"},{"key":"R23-25-20210208","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.amjhyper.2005.05.014","article-title":"Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension","volume":"18","author":"Pierdomenico","year":"2005","journal-title":"Am J Hypertens"},{"key":"R24-25-20210208","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0895-7061(97)00318-X","article-title":"White-coat resistant hypertension","volume":"10","author":"Mezzetti","year":"1997","journal-title":"Am J Hypertens"},{"key":"R25-25-20210208","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.282.6.539","article-title":"Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension","volume":"282","author":"Staessen","year":"1999","journal-title":"JAMA"},{"key":"R26-25-20210208","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/01.CIR.81.2.528","article-title":"Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension","volume":"81","author":"Verdecchia","year":"1990","journal-title":"Circulation"},{"key":"R27-25-20210208","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijcard.2005.08.038","article-title":"Nondippers are associated with adverse cardiac remodeling and dysfunction (R1)","volume":"112","author":"Seo","year":"2006","journal-title":"Int J Cardiol"},{"key":"R28-25-20210208","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0735-1097(02)02535-4","article-title":"Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and nondippers","volume":"40","author":"Higashi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R29-25-20210208","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/01.HYP.31.3.843","article-title":"Circadian blood pressure variation in hypertensive patients with primary hyperaldosteronism","volume":"31","author":"Mansoor","year":"1998","journal-title":"Hypertension"},{"key":"R30-25-20210208","doi-asserted-by":"crossref","first-page":"51","DOI":"10.33549\/physiolres.930042","article-title":"Twenty-four hour blood pressure profile in subjects with different subtypes of primary aldosteronism","volume":"50","author":"Zelinka","year":"2001","journal-title":"Physiol Res"},{"key":"R31-25-20210208","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/08037059309077550","article-title":"Twenty-four-hour power spectral analysis by maximum entropy method of blood pressure in primary hyperaldosteronism","volume":"2","author":"Veglio","year":"1993","journal-title":"Blood Press"},{"key":"R32-25-20210208","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00004872-200018010-00004","article-title":"Controlled study of circadian rhythm of blood pressure in patients with aldosterone-producing adenoma compared with those with essential hypertension","volume":"18","author":"Kimura","year":"2000","journal-title":"J Hypertens"},{"key":"R33-25-20210208","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/10641969409067967","article-title":"In primary aldosteronism the circadian blood pressure rhythm is similar to that in primary hypertension","volume":"16","author":"Penzo","year":"1994","journal-title":"Clin Exp Hypertens"},{"key":"R34-25-20210208","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.jhh.1000422","article-title":"Fourier analysis of circadian blood pressure profile in secondary hypertension","volume":"11","author":"Rabbia","year":"1997","journal-title":"J Hum Hypertens"},{"key":"R35-25-20210208","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1524-6175.2006.05712.x","article-title":"Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases","volume":"8","author":"Ceruti","year":"2006","journal-title":"J Clin Hypertens"},{"key":"R36-25-20210208","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1161\/01.CIR.98.23.2621","article-title":"Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats","volume":"98","author":"Yu","year":"1998","journal-title":"Circulation"},{"key":"R37-25-20210208","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.33.1.232","article-title":"Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats","volume":"33","author":"Rocha","year":"1999","journal-title":"Hypertension"},{"key":"R38-25-20210208","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1291\/hypres.27.303","article-title":"Aldosterone-induced organ damage: plasma aldosterone level and inappropriate salt status","volume":"27","author":"Sato","year":"2004","journal-title":"Hypertens Res"},{"key":"R39-25-20210208","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1161\/01.CIR.0000129307.26791.8E","article-title":"Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism","volume":"109","author":"Nishizaka","year":"2004","journal-title":"Circulation"},{"key":"R40-25-20210208","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1043-2760(01)00432-5","article-title":"Pathophysiological effects of aldosterone in cardiovascular tissues","volume":"12","author":"Rocha","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"R41-25-20210208","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.HYP.21.6.929","article-title":"Vasodilation to acetylcholine in primary and secondary forms of human hypertension","volume":"21","author":"Taddei","year":"1993","journal-title":"Hypertension"},{"key":"R42-25-20210208","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","article-title":"Efficacy of low-dose spironolactone in subjects with resistant hypertension","volume":"16","author":"Nishizaka","year":"2003","journal-title":"Am J Hypertens"},{"key":"R43-25-20210208","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/HJH.0b013e328014954d","article-title":"Low-dose spironolactone in the management of resistant hypertension: a surveillance study","volume":"25","author":"Lane","year":"2007","journal-title":"J Hypertens"},{"key":"R44-25-20210208","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"},{"key":"R45-25-20210208","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1291\/hypres.25.737","article-title":"Dietary sodium restriction restores nocturnal reduction of blood pressure in patients with primary aldosteronism","volume":"25","author":"Takakuwa","year":"2002","journal-title":"Hypertens Res"},{"key":"R46-25-20210208","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF03349173","article-title":"Diurnal blood pressure patterns in patients with primary aldosteronism","volume":"29","author":"Zacharieva","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"R47-25-20210208","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjhyper.2005.01.002","article-title":"Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension","volume":"18","author":"Nishizaka","year":"2005","journal-title":"Am J Hypertens"},{"key":"R48-25-20210208","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"R49-25-20210208","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.amjhyper.2005.06.013","article-title":"True resistant hypertension: is it possible to be recognized in the office","volume":"18","author":"Muxfeldt","year":"2005","journal-title":"Am J Hypertens"},{"key":"R50-25-20210208","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.HYP.18.1.67","article-title":"Sodium and volume sensitivity of blood pressure. Age and pressure change over time","volume":"18","author":"Weinberger","year":"1991","journal-title":"Hypertension"},{"key":"R51-25-20210208","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1378\/chest.06-1442","article-title":"Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension","volume":"131","author":"Pratt-Ubunama","year":"2007","journal-title":"Chest"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004872-200710000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T19:56:20Z","timestamp":1738958180000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-200710000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e3282a9be30","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.720948853.793502392","asserted-by":"object"}]},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}